Sign In
Buy BHC
$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
2 Ben Graham Principles That Are Still Relevant
02:27pm, Friday, 28'th May 2021
Benjamin Graham is widely considered to be the father of value investing. He wrote the first widely-acclaimed book on finding undervalued stocks and using fundamental analysis to choose investments.
2 Ben Graham Principles that Are Still Relevant
02:26pm, Friday, 28'th May 2021
Benjamin Graham is widely considered to be the father of value investing. He wrote the first widely-acclaimed book on finding undervalued stocks and using fundamental analysis to choose investments.
Bausch Health Companies Inc. (BHC) Management Presents at Barclays High Yield Bond Conference (Transcript)
05:44pm, Tuesday, 25'th May 2021
Bausch Health Companies Inc. (BHC) Management Presents at Barclays High Yield Bond Conference (Transcript)
Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes
05:30pm, Monday, 24'th May 2021
LAVAL, QC, May 24, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced its previously announced offering of $1.6 bil
Bausch Health: Buy Ahead Of Bausch + Lomb Spin-Off
08:09am, Thursday, 20'th May 2021
BHC stock could jump higher in anticipation of the upcoming spin-off. Markets not deterred by high debt load.
Bausch Health Companies' (BHC) CEO Joe Papa on Q1 2021 Results - Earnings Call Transcript
02:35pm, Tuesday, 04'th May 2021
Bausch Health Companies' (BHC) CEO Joe Papa on Q1 2021 Results - Earnings Call Transcript
Why Bausch Health Stock Is Falling Today
11:39am, Tuesday, 04'th May 2021
The company's mixed Q1 results are partially to blame.
Bausch reports a $610 million loss in the first quarter of the year
07:52am, Tuesday, 04'th May 2021
Shares of Bausch Health Cos. Inc. were down 2.3% in premarket trading on Tuesday after the company said it faced continued pressure on sales from the COVID-19 pandemic into the first quarter of this y
Bausch Health Exploring Potential Divestiture Of Eye Care Units: Bloomberg
12:36pm, Thursday, 29'th Apr 2021
Bausch Health Companies Inc (NYSE: BHC) said in August that it would spin off its eye-care unit and operate it as an independent, publicly traded company. As a standalone company, Bausch + Lomb coul
The Psychological Biases That Drove Bill Ackman's $4 Billion Valeant Loss
02:15pm, Wednesday, 28'th Apr 2021
In recent years, one of the worst hedge fund trades was Bill Ackman (Trades, Portfolio)'s Valeant (today called Bausch Health Companies Inc. ( BHC , Financial)) debacle.
Xbrane Partners With Bausch & Lomb To Enter USD 12 Billion Market
02:00am, Friday, 16'th Apr 2021
Low-Risk Field - Biosimilars have a 95% FDA approval success rate (36/38 cases). Only two Indian frauds did not pass. Big Market - Xbrane developed a biosimilar product to Lucentis (produced by Roche)
3 Generic Drug Stocks to Watch Amid COVID-Related Recovery
09:09am, Wednesday, 14'th Apr 2021
3 Generic Drug Stocks to Watch Amid COVID-Related Recovery
3 Distressed Stocks for Contrarian Investors to Buy in April
06:00am, Saturday, 10'th Apr 2021
Looking for outside-the-box investments in an overvalued market? Here are your best bets.
Bausch Health to reduce debt by $100 million using cash from operations
07:35am, Wednesday, 07'th Apr 2021
Bausch Health Companies Inc. said Wednesday it will reduce debt by another $100 million using cash from operations to redeem its outstanding 7.00% senior secured notes due in 2024. The company, the fo
Larry Robbins' Firm Jumps Into Longview Acquisition Corp
04:20pm, Monday, 05'th Apr 2021
Larry Robbins ( Trades , Portfolio )'s firm has revealed a new buy into Longview Acquisition Corp. II (NYSE:LGV.U) according to GuruFocus' Real-Time Picks, a Premium feature.
